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 
Abstract— Radiofrequency catheter ablation procedures are 
a first-line method of clinical treatment for atrial fibrillation. 
However, they suffer from suboptimal success rates and are 
also prone to potentially serious adverse effects. These 
limitations can be at least partially attributed to the inter- and 
intra- patient variations in atrial wall thickness, and could be 
mitigated by patient-specific approaches to the procedure. 
In this study, a modelling approach to optimising ablation 
procedures in subject-specific 3D atrial geometries was applied. 
The approach enabled the evaluation of optimal ablation times 
to create lesions for a given wall thickness measured from MRI. 
A nonliner relationship was revealed between the thickness and 
catheter contact time required for fully transmural lesions. 
Hence, our approach based on MRI reconstruction of the atrial 
wall combined with subject-specific modelling of ablation can 
provide useful information for improving clinical procedures. 
 
I. INTRODUCTION 
Atrial fibrillation (AF) is the most common cardiac 
arrhythmia. Effects of AF include a decreased quality of life 
and more serious morbidities including the increased risk of 
stroke [1]. While the underlying mechanisms of AF are not 
completely understood, the arrhythmia is known to arise from 
irregular electrical activity in the atria. Ultimately, clinical 
treatments of AF aim to target this irregular activity. 
Radiofrequency catheter ablation (RFCA) procedures are 
one such treatment. An ablation catheter is used to produce 
electrically inert, transmural lesions in the myocardium to 
isolate or remove areas contributing to the generation or 
maintenance of the activity sustaining AF. However, RFCA 
procedures are not always effective in treating AF. Thus, 
when considering  paroxysmal AF, the success rates for 
pulmonary vein isolations (PVI) are between 38-70% after a 
single procedure, or 65-90% after repeated procedures [2]. 
For persistent cases of AF, PVI alone is not sufficient and 
further areas of the atrial wall are targeted. Moreover, RFCA 
procedures are not without risks, and major complications 
have been found to occur in 4.5% of patients [3]. 
High inter- and intra- patient variations in atrial wall 
thickness (AWT) presents a major issue when creating the 
transmural lesions required for effective RFCA treatments. 
Patient-specific knowledge of AWT could provide clinicians 
with useful information to optimise the ablation procedure by 
using the minimal amount of RF energy, thereby improving 
the efficacy of the procedure by ensuring the optimal catheter 
contact time to achieve lesion transmurality. Furthermore, 
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patient-specific knowledge could also reduce the risk of 
complications. For example, PV stenosis can be avoided by 
minimising catheter contact time at target areas of the atrial 
wall to ensure temperatures stay below noted risk levels [4]. 
Such a patient-specific approach requires information of 
the AWT variations throughout the atria. Until recently, the 
existing medical imaging modalities failed to provide 
detailed AWT information for human subjects. However, 
recent developments of novel magnetic resonance imaging 
(MRI) protocols have enabled detailed AWT reconstruction 
[5]. This opens up new pathways towards the patient-specific 
evaluation and prediction of thermal effects during RFCA. 
Since testing of novel approaches in a clinical setting can be 
extremely difficult, computational modelling has emerged as 
an increasingly accepted method of virtual evaluation [6]. 
This study aims to apply computational modelling to 
simulate RFCA of subject-specific atrial wall geometries [5]. 
This will provide novel information on the catheter contact 
time required to achieve transmural ablation lesions in atrial 
tissue with different thicknesses. Thus, the optimal time for 
producing fully transmural ablation lesions will be found for 
specific AWT. Finally, a PVI procedure will be simulated on 
a realistic atrial geometry to test the efficacy in the model. 
The model predictions could potentially be used to develop 
patient-specific approaches to RFCA procedures in the clinic. 
II. METHODS 
A. 3D atrial geometry reconstruction 
A healthy volunteer was imaged in a Phillips 3T Achieva 
scanner [5]. Images were acquired in a para-axial plane using 
a black blood PSIR sequence with 1.4-mm isotropic 
resolution. Cardiac triggering was performed in late atrial 
diastole, which was identified from the visual inspection of a 
4-chamber CINE image, as is commonly done in the clinical 
setting. The images were manually segmented using ITK 
snap, and in-house Matlab scripts were then utilised to 
process and interpolate the segmented data to produce a 
higher 0.47mm
3
 resolution 3D atrial geometry (Figure 1). 
The latter was used as the basis for the 3D model for ablation 
(see below), providing a subject-specific AWT distribution.  
B. Model development and validation 
The ablation procedure was modelled in two stages. 
Firstly, the propagation of heat throughout the tissue due to 
the ablation catheter was computed by solving the modified 
Pennes bioheat equation in the following form [7,8]:  
    
  
  
                       
                      
Here ρ is the density of the tissue (kg/m3),   is the specific 
heat capacity of the tissue (J/kg K),   is the thermal 
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conductivity of the tissue (W/m K),           is the heat 
applied by the catheter (W/m
3
),    is the perfusion heat loss 
(W/m
3
) and    is the metabolic heat gain (W/m
3
).    and 
   were omitted due to their negligible magnitude.  
In Equation 1,           was calculated using the Laplace 
equation with the tissue electrical conductivity   (S/m):  
                
           
The equations were solved using the finite differences 
method on the reconstructed 3D atrial geometry, with a 
spatial step of 0.47mm and a temporal step of 5ms. Further to 
this, the tissue geometries were initialised with a uniform 
temperature of 310.15K and uniform potential of 0V. The 
catheter was modelled based on a 7-french  geometry (2.33 
mm diameter), matching both clinical standards and previous 
studies [7,8]. The catheter was modelled as perpendicular to 
the endocardial tissue surface, which produced radially 
symmetric ablation and heat propagation patterns. 
To model tissue damage, the Arrhenius method was used:  
         
   
        
    
    
 
 
 
            (3) 
                                        
Here the integral limits are over the time period of 
ablation,    is the rate factor measuring molecular collisions 
(s
-1
),    is the energy barrier the tissue must overcome to be 
denatured (J/mol),   is the gas constant (8.3134 J/mol K) and 
  is the temperature of the tissue (K).      is a dimensionless 
value, and can be interpreted as the logarithmic ratio between 
the initial volume of undamaged tissue and the volume of 
damaged tissue at time  . An  -value of 1 or greater signifies 
63% irreversible tissue damage, while a value greater than 
4.3 signifies 99% irreversible tissue damage [9]. This 
equation was solved concurrently with Equation 1 for T. 
The Arrhenius method was preferred over temperature 
isotherms, as the latter method has been demonstrated to 
overestimate the lesion size [10]. More crucially, the 
parameters affecting lesion growth (  and   ) could be 
sourced from literature enabling the model to be tuned to 
produce ablation times in accordance with empirical data, 
specifically ablation times between 30s and 60s [11]. 
Table 1 shows the values of physical constants utilized by 
this model, which were taken from previous studies [12,13]. 
The model was initially validated using a 26.32mm square 
slab of atrial wall adjacent to the right inferior PV. This was 
due to the section being a typical example of a realistic 
ablation target in a clinical environment. The temperature 
propagation was tested before implementing the damage 
modelling, and the ablation times were tested against clinical 
data to ensure the efficacy of the model. The appropriate 
values for    and     were found at this point to  ensure  that 
TABLE I. PHYSICAL CONSTANTS USED IN THE MODEL 
Physical constants 
  
 (kg·m-3) 
  
(J/kg K) 
   
(W/m K) 
  
(S/m) 
  
 (s-1) 
   
(J/mol) 
1200 3200 0.550 0.222 1.28×1022 145 000 
 
damaged tissue with        corresponded to 323.15K 
tissue temperatures and ablation times between 30s and 60s. 
Thus, the model parameters and outcomes on test simulations 
in atrial slabs were in agreement with previous studies [7,8]. 
Note that this model did not include cooling effects from 
the blood flow in the atria, and also kept the electrical 
conductivity of the tissue constant throughout. While these 
can be physically significant [14], this was done to keep the 
model simple and focus on the effects of atrial geometry.  
C. Simulation of ablation in atrial slabs  
To explore relationships between the AWT and catheter 
contact time, 3D atrial slabs were generated at thicknesses 
ranging from 0.94mm to 5.64mm, in increments of 0.47mm. 
These values corresponded to the AWT measurements in the 
reconstructed subject-specific atrial geometry. The catheter 
was applied at the centre of the top surface of each slab, and a 
marker point on the opposite side was monitored to check its 
temperature and  -value, so as to flag when the lesion had 
reached transmurality (with       ). The ablation 
simulation for each AWT ran for an arbitrarily long period of 
time to allow for this to happen, with a constant catheter 
voltage of 10V, and an effective catheter depth of 0.47mm. 
Similar simulations of transmural lesions were then run 
on 3D atrial slabs extracted from representative locations in 
the subject-specific 3D atria reconstruction (see Figure 2). 
D. Simulation of pulmonary vein isolation 
The right inferior PV was targeted in the simulated PVI. 
Ablation points were selected to replicate a realistic clinical 
procedure, with the points close enough to one another to 
enclose the RIPV completely, while also maintaining some 
distance from the PV ostium. From a clinical viewpoint, this 
is done to enclose more potential AF triggers or re-entry 
areas while also mitigating the risk of PV stenosis. The 
catheter was applied at each point on the endocardial surface 
with a constant voltage of 10V. A congruent monitoring point 
was then selected on the epicardial surface to flag when the 
ablation had reached full transmurality, and the simulation 
ran for each point until this had been achieved. Note that each 
ablation point was simulated independently of the others. 
 
Fig. 1. Illustration of the final segmentation of the subject-specific atrial 
MRI scan. Dark blue sections represent the atrial walls, the red section 
represents the aorta (partially obscured by the superior vena cava, SVC), the 
yellow sections (left) show the branching right inferior pulmonary vein 
(RIPV) and the light blue section represents the inferior vena cava (IVC). 
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III. RESULTS 
A.  Ablation of realistic atrial geometries 
Figure 1 shows the segmented 3D atrial geometry that 
proved a good platform for the computational framework. 
Only the left atrium and PVs were used for the ablation 
simulations, since these are the most common targets for 
clinical RFCA [1]. AWT computed in these regions ranged 
from 1mm in distal PVs to 5mm in the left atrial appendage, 
which was in good agreement with anatomical knowledge. 
Figure 2 illustrates the temperature distribution during 
several time steps of a simulated ablation procedure. During 
ablation of a region of the atrial wall with an average AWT 
of about 4 mm, a fully transmural lesion was formed after 
about 75ms (Figure 2c). This is in agreement  with the 
respective results obtained for atrial slabs of varying uniform 
thickness (Figure 3). The lesion was substantially wider at the 
endocardial surface where the catheter was applied, with 
quasi-spherical heat propagation through the wall resulting in 
a narrow lesion on the opposite epicardial side (Figure 2c). 
The lesion widths became more uniform on both surfaces 
(i.e., fully transmural) after about 100ms (Figure 2d).  
Note that, when viewed from the surface, the lesion 
exhibited radial symmetry about the catheter centre point, as 
expected (not shown). The glowing effect at the borders of 
the atrial tissue (Figure 2) was a result of the implementation 
of the zero-flux boundary conditions, where temperature at 
the boundary was designated the same value as the adjacent 
tissue temperature, ensuring no temperature flux through the 
tissue surface. In real atria, such an effect would correspond 
to the heat spread into the adjacent pericardium and blood. 
An optimal catheter voltage of 10V was found to  
produce realistic heat spread and tissue damage parameters, 
as well as the most efficient ablation times [13]. These results 
effectively validate the choice of model parameters. 
 
 
Fig. 2. Heat distribution maps for the subject-specific 3D atrial geometry. 
One section of atrial wall is shown (viewed transmurally) with the addition 
of a catheter at the top (endocardial surface). The temperature scale is shown 
on the left. Different moments of time throughout the ablation simulation are 
shown: (a) 1 second, (b) 25 seconds, (c) 75 seconds and (d) 100 seconds. The 
semi-transparent grey grid shows the transmural cross section of the atrial 
wall. Bright red corresponds to the increasingly heated catheter and lighter 
red shows the heat spreading through the wall and also into boundary layers. 
B. Catheter contact time vs. tissue thickness 
The simulated relationship between the catheter contact 
time required for lesion transmurality and AWT is shown in 
Figure 3. The relationship is nonlinear, showing a linear 
phase only for relatively thick walls, but increasingly 
diverging from a straight line as the wall thickness decreases. 
The nonlinear phase becomes especially apparent for AWT 
below 3mm. Since the average thickness of  the left atrial 
wall is about 2mm [5,15], an assumption about a simple 
linear relationship between the AWT and contact time 
relation cannot be used for most clinically relevant situations.  
 
Fig. 3. Catheter contact time required for transmural lesion formation for 
different tissue thicknesses. Data points come from simulations of 3D atrial 
slabs of varying thickness, and results of simulating 3D slabs taken from the 
subject-specific atrial geometry fall onto the same curve (see Figure 2). The 
straight line represents a linear trend for the AWT values above 3mm. 
Note that the simulated ablation times per tissue point are 
in the range from 10 to 130 ms, depending on AWT. These 
are much faster than the actual ablation times in a clinical 
setting. Note also that the electrical tissue conductivity can  
increase by 1.5-2% for every 1 degree rise in temperature 
[16]. If this behaviour had been accounted for in this study, 
this would have lead to an even faster rate of lesion 
formation. This provides further evidence to the fact that 
clinical RFCA procedures may not be time-efficient, and that 
the knowledge of AWT can be used to optimise them.  
C. Simulation of pulmonary vein isolation 
Figure 4 shows the results of simulating PVI procedures 
in the realistic subject-specific 3D atrial geometry. In the 
simulations, the RIPV was fully isolated within about 30 
minutes of catheter contact time. This is substantially faster 
than clinical RFCA procedures blinded to AWT. The 
simulation produced continuous, fully transmural lesions 
isolating the PV. It should be noted that the lesion widths at 
points of high AWT became relatively large (about 10mm). 
This was a natural consequence of the longer ablation times 
required for achieving the lesion transmurality, combined 
with the radially symmetric growth of the lesions. In the 
clinic this could have adverse effects on the mechanical 
properties of the atrium, such as decreased tissue elasticity.  
IV. CONCLUSION 
We developed a modelling approach to optimising RFCA 
in subject-specific 3D atrial geometries (Figure 1). The 
approach enabled measuring the optimal ablation times to 
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achieve lesions with sufficient tissue transmurality for a 
given AWT (Figure 2). Moreover, we found a qualitative 
relationship between the AWT and catheter contact time 
required to create transmural lesions. The relationship is 
nonlinear, with a substantial divergence from a straight line 
for AWT below 3mm (Figure 3). Since AWT information 
can be obtained from subject-specific MRI [5], utilizing such 
information during a clinical RFCA procedure has a potential 
to improve its efficacy, as well as minimise the related risks.  
Similar MRI techniques can easily be applied to measure 
AWT in AF patients after their cardioversion to sinus rhythm, 
which is commonly performed before ablation procedures. 
Computed tomography may also provide information about 
AWT, but this modality is prone to poor soft tissue contrast. 
In proof-of-concept simulations, we also evaluated 
ablation patterns required for subject-specific PVI (Figure 4), 
with estimates of the procedure time and tissue damage. The 
simulated procedures were relatively quick (~30 minutes), 
although the fully transmural lesions were achieved at an 
inevitable price of wide lesions in regions of high AWT. 
While the model had its limitations, it did demonstrate the 
viability of patient-specific evaluation of RFCA procedures, 
which could provide useful information for the clinic and 
ultimately lead to the improved clinical treatment of AF. 
 
 
 
 
 
 
 
 
 
Fig. 4. Result of the PVI simulation in the subject-specific 3D atrial model. 
The blue areas represent the atrial wall, while the red areas represent lesion 
tissue where      . The right panel shows the epicardial view and the left 
panel shows the endocardial view, and the respective two arrows show the 
right inferior pulmonary vein (RIPV) and the ostium of the RIPV. 
Limitations of the model include disregarding cooling 
effects by the blood in the atria, which may lead to a decrease 
of the lesion formation times [14], as well as the use of one 
specific catheter geometry [7,8]. A study by Gallagher et al. 
[7] has suggested that changing the catheter depth and angle 
would vary the ratio of the lesion depth to the lesion width. 
This would more accurately model a real ablation scenario 
where a 90° contact angle (as used in our study) is not 
always implemented or feasible. Addressing these two 
limitations in future studies could help to find optimal 
clinical strategies for creating transmural lesions with the 
optimal time and minimal amount of tissue damage. 
Finally, it would be useful to combine the current model 
with electrophysiologically and anatomically detailed 3D 
atrial models [6] and test the efficacy of different ablation 
strategies in treating the mechanistic factors underlying AF. 
For example, areas which demonstrate irregular electrical 
activity could have corresponding ablation patterns imposed 
on them to test customised, patient-specific RFCA therapy. 
In summary, this study developed a modelling approach 
to optimising RFCA in subject-specific 3D atrial geometries. 
The results demonstrated the viability of a patient-specific 
evaluation of the optimal ablation times for a given atrial wall 
geometry, which could potentially provide clinicians with 
valuable data and improve the efficacy of RFCA procedures.  
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